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Veterans Administration Hospital. Denver. CO 80:!:!O. U.S. A. 
Pro\'iding the anatomic conditions are appropriate, removal of as much as 85-90% of the liver 
is a relatively safe technique for the treatment of benign or malignant prlmal) hepatic tumors 
and of isolated hepatic metastases. There have been apparent cures of malignant disease by 
this approach, but the paucity of concentrated experience at anyone center and the failure so 
far to pool data from ditlerent centers electively make a valid prognosis impossible. 
Total hepatectomy and liver replacement has resulted in the apparent cure of some 
patients with primary hepatic malignancy. However, tbere bas been an extremely higb rate of 
recurrence of tumor. Small cancers which are lethal because of their strategic locations may 
provide an unusually good indication for liver replacemenL Liver transplantation would 
rarely, if ever, be indicated for metastases to tbe liver. 
Primary and metastatic liver neoplasms, Surgery, Hepatic ceD carcinoma. 
INTRODUCTION 
The last 15 years have seen very important 
advances in two areas of hepatic surgery. 
First, techniques have been perfected which 
permit the relatively safe removal of as much 
as 85-90% of the liver. Second. it has become 
feasible to carry out total removal of a 
diseased liver and to replace it with a hepatic 
homograft. 
How have these powerful new tools 
affected the treatment of primary and metasta-
tic tumors of the liver. and to what extent will 
'. future policies of cancer therapy be shaped by 
their more extensive use? 
DIAGNOSIS 
Primary tumors 
Hepatic tumors may present as asymptoma-
tic or symptomatic masses in the liver area. or 
by a variety of other manifestations including 
distant metastases. A liver scan will help 
define the extent of the lesion. Since more 
than 90% of hepatic tumors are metastatic. it 
is important to search for a primary malig-
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nancy elsewhere. Gastrointestinal series, 
barium enema. intravenous urogram, and 
metastatic surveys of the chest and bones are 
usually indicated. Unless some reason has 
been found with these studies not to proceed. 
angiograpbic study of the hepatic aterial supply 
is performed (Fig. 1). Transhepatic and retrog-
rade (transduodenal) cholangiography are very 
useful procedures if jaundice is a symptom. 
In all patients with hepatic masses. the 
presence and amount of alpha fetoprotein is 
important. This is a protein of the alpha. 
globulin class which is synthesized by undif-
ferentiated hepatoma cells and which is found 
in the serum of 30-90% of patients with liver 
cell carcinoma. False positive tests from 
hepatic metastases have been documented 
only in a few pediatric patients with primary 
embryonal malignant lesions. Thus. not only 
does a positive tc~st str6nglY support the 
diagnosis of a primary liver cell carcinoma. 
but later quantitative determinations are of 
great help in following the progress and 
effectiveness of treatment. t 
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Fig. 1. Arteriogram performed prior to trisegmentectomy for hepatic adenoma in a 16 year 
old girl. The entire liver was supplied by an anomalous artery (A) arising from the superior 
mesenteric artery (SMA). Branches to the right lobe and to the medial segment of the left 
lobe were ligated (large arrows), preserving the main trunk and its tiny branch to the left 
lateral segment (small arrow). 
Isolated liver metastases 
The diagnosis of isolated hepatic metastases 
after the resection of a primary malignancy 
elsewhere is apt to result either from careful 
follow-up physical examination or from serial 
liver scans (Fig. 2). 
OPERATIVE EVALUATIONS 
In the absence of contraindications such as 
proven metastases. abdominal exploration 
usually should be "performed without delay to 
obtain a tissue diagnosis and with a view to 
curative resection if feasible. From the biopsy 
tissue. the accurate and rapid histopathologic 
classification of liver masses is essential. A 
potentially serious error is to fail to recognize 
a lesion known as focal nodular hyperplasia. 
These masses. which are not true neoplasms. 
do not ordinarily require major resection and 
usually should be left alone except for biopsy. 
There are exceptions to this generalization. 
since rupture and massive bleeding have been 
reported.8 particularly with large areas of 
involvement which may cause pressure symp-
toms in addition. We have performed triseg-
mentectomy for a patient with such extensive 
disease. Histopathologically. the nodules. 
which have a cobblestone appearance. are 
composed of uniformly normal appearing liver 
cells in cords or sheets, usually without 
orientation to central veins or portal triads. 
which are sparse. There may be areas of 
fibrosis. infarction or hemorrhage.s 
A particular solid hepatic neoplasm has a 
special place by virtue of its occasional huge 
size. slow natural history and failure to 
metastasize. These characteristics. which 
were particularly well recognized by Edmon-
ston: have caused this tumor to be called 
benign hepatoma. mInimUm deviation 
hepatoma or adenoma. Another designation 
has been "pill tumor" because of the frequent 
association of these neoplasms in young 
women with the ·use of oral contraceptive 
.j 
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': . Pia. 2. Routine liver scans in 2 patients with i ~ticK metastases fr.om colon c~ncerK Top. An-
i' 1erior hver scan showmg a defect m the left lateral 
~: teament which subsequently was resected. Bottom. Jt:!.. Posten.. 'or liver scan. A large defect involves the . :lipt lobe and medial segment of the left lobe. ~;K" Trisegmentectomy was performed. 
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:" drugs. Alpha fetoprotein determinations are 
; .. negative. 
;: The tendency of hepatic adenomas to 
t rupture has made their presence in the liver 
~K like a time bomb. Berg et al. noted 4 cases of 
DK~ this tumor in the Iowa State Cancer Registry; 
in 3 the tumor ruptured and lethal hemorrhage 
OCCurred.2 Two of our 6 women with hepatic 
adenomas have presented with massive bleed-
• ing. Both cases illustrated that serious errors 
~: of treatment-planning or interpretation of 
. results are possible without an accurate 
diagnosis. After emergency hepatic lobec-
tomy, the 2 women carried the diagnosis of 
hepatoma and were treated with 5-ftuorouracil 
for more than 2 years before the pathologic 
specimens were reviewed and reclassified. If 
there are doubts about the diagnosis. speci-
mens should be sent to reference centers such 
as the Armed Forces Institute of Pathology. 
Washington. DC 20305. 
Hepatic cell carcinoma (hepatoma) ac-
counts for 80-90% of the malignant primary 
hepatic neoplasms. Cholangiocarcinoma is 
next in frequency. Both tumors may be 
multifocal. The list o'f unusual or rare malig-
nancies is a long one, including hemangio-
endothelial sarcoma, squamous cell carcinoma 
in an intrahepatic cyst and carcinoma of the 
larger intrahepatic ducts. Patients with the last 
kind of neoplasm may be candidates for liver 
transplantation (see below). 
PARTIAL HEPATECTOMY 
The limits of safe removal 
The human liver consists of four segments. 
The units which lend themselves to excision 
(Fig. 3) include the right and left true lobes 
(each consisting of two segments). the true 
right lobe plus the medial segment of the left 
lobe (trisegmentectomy or extended right 
lobectomy) and the lateral segment of the left 
lobe. In planning the appropriate operation, 
the dissection is so greatly facilitated by 
preoperative arteriography (Fig. l) that this 
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Fig. 3. The common hepatic resections. of which 
there are only four. The most radical procedure. 
trisegmentectomy. involves removal of the true 
right lobe plus the medial segment of the left lobe. 
The least radical procedure. lateral segmentectomy. 
was incorrectly termed left lobectomy in the older 
literature. 
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study is performed in every candidate for 
partial hepatectomy. unless it is contraindi-
cated. 
The historically high risk of hepatic resec-
tion has been reduced drastically in recent 
years. In the personal experience of the senior 
author with about 30 cases at the University of 
Colorado no patient has died after partial 
hepatectomy since 1962. The numbers of 
hepatic resections have increased steadily; 20 
of our partial hepatectomies have occurred 
since 1970. including only one segmentec-
tomy. Of these last 20 patients, trisegmentec-
tomy was performed in 8, and removal of 
conventional lobes in the rest. 
Surgical treatment 
As has already been emphasized. a final 
diagnosis is frequently impossible until opera-
tion. and sometimes not even then. If. at 
exploration. the lesion in question is thought 
to be: other than focal nodular hyperplasia: 
resectable: and localized to the liver. enough 
liver is removed by one of the formal 
resections shown in Fig. 3 to excise the mass 
with as full a margin as possible. The 
piecemeal removal of hepatic masses, even 
those thought to be benign, is almost never 
justifiable from a technical point of view if the 
amount of excised tissue is more than 100 or 
200g. 
The special question of metastases 
If there is a resectable primary hepatic 
tumor. no one would seriously argue against 
its removal with as wide margins as possible. 
Although large series cannot be cited as the 
basis for a prognosis. nurqerous reports have 
proved that both hepatomas and cholangiocar-
cinomas can be cured.h ; 
The expectations after resection for hepatic 
metastases are even less clear. With the 
exception of carcinoid tumors. there is sur-
prisingly little actual experience with partial 
hepatectomy for metastatic disease. The 
world literature was surveyed by Flanagan 
and Foster in 19STK~ They found 32 reports 
involving n patients who had survived liver 
resection. The primary malignancy was col-
onic in 45 instances. The overall 5-year 
survival for the 72 patients was 24%. The 
correlation of the time interval between 
primary and secondary operation with prog-
nosis was not good. The kind of primary 
tumor was influential; metastases from sar-
comas and colon carcinomas were most 
effectively treated. 
Since the lure of describing successes 
exceeds the temptation to report failures, the 
compilation of Flanagan and Foster may be an 
overstatement of the therapeutic expecta-
tions. In a personal series of 11 cases 
Longmire et al.' report that 10 of their patients 
died of recurrent disease 2-18 months after_ 
hepatic resection. The single survivor was -. 
alive after 16 months. On the other hand, in a 
similar series of eight. DilIard3 recorded 5 long 
term survivors; 4 of these had lived from 4 to 
10 years after partial hepatectomy without 
evidence of recurrence. 
In the last 13 years. we have performed 
partial hepatectomy for metastatic disease 
only upon the patients shown in Fig. 2. The 
paucity of our experience and that elsewhere 
undoubtedly reflects the tendency of liver 
metastases to be widespread once they occur. 
However. a further factor could be a bias 
against using secondary partial hepatectomy 
because of its reputed high mortality. The 
reduction in operative risk in recent times 
should encourage an aggressive approach. 
A need for pooled data 
Even major oncology centers have a similar 
problem accumulating sufficient cases to draw 
valid conclusions about the value of hepatic 
resection for both primary and secondary 
neoplasms; therefore the use of pooled regis-
tries to develop prognostic data should be 
obvious objectives of oncology centers spr-
inging up under the stimulus of federal 
funding. Furthermore. information is needed 
about the postresectional role of adjuvant 
therapy with drugs or irradiation. The tacit 
assumption is usually made that neither 
irradiation or chemotherapy are safe or 
effective following subtotal hepatectomy. 'but 
such negative attitudes may eventually prove 
to be completely unjustifiable. Several of our 
recent patients have been treated with the 
triple drug regimen of cyclophosphamide, 
5-fluorouracil and vincristine sulphate. I 
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Therapy was not started for several weeks 
after operation until regeneration had a 
chance to begin and good wound healing was 
evident. Two of these patients who had 
massive tumors with blood vessel invasion are 
clinically free of tumor after f-~ years. 
TOTAL HEPATECTOMY A~a 
TRANSPLANTA TION 
The appeal of liver replacement for the 
treatment of hepatic cancers is that the 
boundaries of permissible resection could be 
considerably expanded. Some liver tumors 
which cannot be completely excised by 
standard techniques of subtotal hepatectomy 
would become removable if the whole organ 
could be extirpated. 
A potentially self-defeating aspect 
. . Of course, the extension by this means of 
the surgical procedure would not insure 
• against metastases. Indeed there is the possi-
bility that the growth of residual tumor could 
actually be accelerated as a consequence of 
the immunosuppressive therapy which is 
necessary for prevention of homograft rejec-
tion. This would be expected if the concept is 
valid that the immunologic system provides a 
surveillance function by which mutant neo-
plastic cells are identified and either eliminated 
or restricted in their growth potential. The 
individuality of such cells which allows their 
recognition as foreign has been thought to 
result from tumor specific antigens. 
K~K It has been thoroughly documented 
elsewhere9 that immunosuppression leads to a 
.. striking incidence of new tumors and that it 
permits the transplantation of malignant 
tumors in humans which may become au-
tonomous and, therefore. deadly even if 
immunosuppression is stopped. It has not 
been proven that metastases are enhanced by 
immunosuppressive therapy but the. strong 
possibility has been raised from observations 
with patients treated with hepatic replacement 
for primary malignancies of the liver.q 
In our own experience, seven patients with 
malignant liver tumors. exclusive of three with 
carcinomas of intrahepatic bile ducts. have 
undergone surgery for hepatic replacement 
with subsequent survinl.1 for long enough tll 
permit meaningful observations about tumor 
recurrence. The diagnoses were hepatoma in 6 
cases and hemangioendothelial sarcoma in the 
other. Six of the patients developed metas-
ta$es and all were dead 2.5-14 months after 
transplantation. usually <1,\ the re'\ult of the 
neoplasm. The only exception was a 3 year old 
child whose liver. which had been destroyed 
by biliary atresia. contained a 2 cm incidental 
hepatoma. After transplantation. the elevated 
serum alpha fetoprotem disappeared and more 
than 5 years later. there is no evidence of 
recurrence. 
R. Y. Caine of Cambridge. P. Daloze of 
Montreal (oral communication. London. 
March 4, 1975) and J. B. Fortner of New York 
(oral communication. Mexico City. October 
18. 1974) collectively have also had a few long 
survivals after liver replacement in patients 
with primary liver tumors. However. the 
salvage rate, which is nct yet satisfactory after 
transplantation even for the treatment of 
Fig. 4. Transhepatic cholangiogram with which a 
cholangiocarcinoma obstructing the main hepatic 
duds was diagnosed. The patient is well. without 
evidence of recurrent disea~eI 1 year after or-
thotopic liver transplantation. 
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non-neoplastic liver disease. will obviously be 
drastically further depreciated in cancer pa-
tients. 
It is hard to imagine for the same general 
reasons already stated that liver replacement 
will ever play much of a role in the treatment 
of metastatic liver disease. 
A possible exceptiOn 
Carcinomas at the junction of the right and 
left hepatic ducts are being accurately diag-
nosed at an earlier time. with increased use of 
transhepatic and transduodenal cholangiog-
raphy. Because of the strategic location of the 
lesion (Fig. 4), jaundice develops early and 
often prompts medical evaluation when the 
tumor is still very small and potentially highly 
curable. 
We have performed liver replacement for 3 
such patients. One died of surgical complica. 
tions a few weeks later. Another died after 2 
years of recurrent tumor in the homograft. The 
third patient is well without evidence of 
recurrent tumor 1.75 years after transplanta. 
tion. Further experience will be necessary to 
determine if this approach will be preferable to 
the palliative methods designed to decompress 
the obstructed biliary passages that have been 
used in the past. 
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